The Efficacy of Cognitive-Behavioral Therapy and Psychodynamic Therapy in the Outpatient Treatment of Major Depression: A Randomized Clinical Trial

被引:134
|
作者
Driessen, Ellen [1 ]
Van, Henricus L.
Don, Frank J.
Peen, Jaap
Kool, Simone
Westra, Dieuwertje
Hendriksen, Marielle
Schoevers, Robert A.
Cuijpers, Pim
Twisk, Jos W. R.
Dekker, Jack J. M.
机构
[1] Arkin Mental Hlth Care, Amsterdam, Netherlands
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2013年 / 170卷 / 09期
关键词
SUPPORTIVE PSYCHOTHERAPY; METAANALYSIS; PHARMACOTHERAPY; SYMPTOMATOLOGY; SEVERITY; ADULTS;
D O I
10.1176/appi.ajp.2013.12070899
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The efficacy of psychodynamic therapies for depression remains open to debate because of a paucity of high-quality studies. The authors compared the efficacy of psychodynamic therapy with that of cognitive-behavioral therapy (CBT), hypothesizing nonsignificant differences and the noninferiority of psychodynamic therapy relative to CBT. Method: A total of 341 adults who met DSM-IV criteria for a major depressive episode and had Hamilton Depression Rating Scale (HAM-D) scores >= 14 were randomly assigned to 16 sessions of individual manualized CBT or short-term psychodynamic supportive therapy. Severely depressed patients (HAM-D score >24) also received antidepressant medication according to protocol. The primary outcome measure was posttreatment remission rate (HAM-D score <= 7). Secondary outcome measures included mean posttreatment HAM-D score and patient-rated depression score and 1-year follow-up outcomes. Data were analyzed with generalized estimating equations and mixed-model analyses using intent-to-treat samples. Noninferiority margins were prespecified as an odds ratio of 0.49 for remission rates and a Cohen's d value of 0.30 for continuous outcome measures. Results: No statistically significant treatment differences were found for any of the outcome measures. The average posttreatment remission rate was 22.7%. Noninferiority was shown for posttreatment HAM-D and patient-rated depression scores but could not be demonstrated for posttreatment remission rates or any of the follow-up measures. Conclusions: The findings extend the evidence base of psychodynamic therapy for depression but also indicate that time-limited treatment is insufficient for a substantial number of patients encountered in psychiatric outpatient clinics.
引用
收藏
页码:1041 / 1050
页数:10
相关论文
共 50 条
  • [41] Cognitive-Behavioral Therapy for Intermittent Explosive Disorder: A Pilot Randomized Clinical Trial
    McCloskey, Michael S.
    Noblett, Kurtis L.
    Deffenbacher, Jerry L.
    Gollan, Jackie K.
    Coccaro, Emil F.
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2008, 76 (05) : 876 - 886
  • [42] The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: A randomized controlled trial
    Misri, S
    Reebye, P
    Corral, M
    Milis, L
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (09) : 1236 - 1241
  • [43] Telephone Cognitive-Behavioral Therapy for Subthreshold Depression and Presenteeism in Workplace: A Randomized Controlled Trial
    Furukawa, Toshi A.
    Horikoshi, Masaru
    Kawakami, Norito
    Kadota, Masayo
    Sasaki, Megumi
    Sekiya, Yuki
    Hosogoshi, Hiroki
    Kashimura, Masami
    Asano, Kenichi
    Terashima, Hitomi
    Iwasa, Kazunori
    Nagasaku, Minoru
    Grothaus, Louis C.
    PLOS ONE, 2012, 7 (04):
  • [44] Peer-Delivered Cognitive-Behavioral Therapy for Postpartum Depression: A Randomized Controlled Trial
    Amani, Bahar
    Merza, Donya
    Savoy, Calan
    Streiner, David
    Bieling, Peter
    Ferro, Mark A.
    Van Lieshout, Ryan J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (01)
  • [45] Culturally Adapted Cognitive-Behavioral Therapy for Chinese Americans With Depression: A Randomized Controlled Trial
    Hwang, Wei-Chin
    Myers, Hector F.
    Chiu, Eddie
    Mak, Elsie
    Butner, Jonathan E.
    Fujimoto, Ken
    Wood, Jeffrey J.
    Miranda, Jeanne
    PSYCHIATRIC SERVICES, 2015, 66 (10) : 1035 - 1042
  • [46] Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression - Treatment for adolescents with depression study (TADS) randomized controlled trial
    March, J
    Silva, S
    Petrycki, S
    Curry, J
    Wells, K
    Fairbank, J
    Burns, B
    Domino, M
    Vitiello, B
    Severe, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (07): : 807 - 820
  • [47] Cognitive Function and Treatment Response in a Randomized Clinical Trial of Computer-Based Training in Cognitive-Behavioral Therapy
    Carroll, Kathleen M.
    Kiluk, Brian D.
    Nich, Charla
    Babuscio, Theresa A.
    Brewer, Judson A.
    Potenza, Marc N.
    Ball, Samuel A.
    Martino, Steve
    Rounsaville, Bruce J.
    Lejuez, Carl W.
    SUBSTANCE USE & MISUSE, 2011, 46 (01) : 23 - 34
  • [48] The Efficacy of Cognitive-Behavioral Therapy for Depression: Reflections on a Critical Discussion
    Dobson, Keith S.
    CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE, 2016, 23 (02) : 123 - 125
  • [49] Cognitive-behavioral therapy for psychosis: A naturalistic clinical trial
    Marois, MJ
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 57 - 57
  • [50] MODERATORS OF CHANGE IN PSYCHOANALYTIC, PSYCHODYNAMIC, AND COGNITIVE-BEHAVIORAL THERAPY
    Huber, Dorothea
    Henrich, Gerhard
    Klug, Guenther
    JOURNAL OF THE AMERICAN PSYCHOANALYTIC ASSOCIATION, 2013, 61 (03) : 585 - 589